ALK and colorectal carcinoma: Given the relative low incidence of ALK rearrangement in CRC and the unknown clinical significance of this rearrangement in CRC, a routine and cost-effective diagnostic assay is needed to allow broad screening for ALK rearrangement in CRC and identify these patients for potential enrollment into clinical trials.